Company: AEMD
Filing Date: 2025-11-06
Form Type: 8-K
Source: 0001683168-25-008001
Chunk: 0

Company: AETHLON MEDICAL INC
Filing Date: 2025-11-06
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events

On November 5, 2025,
Aethlon Medical, Inc., a Nevada corporation (the “ Company”) received a letter from the Nasdaq Listing Qualifications Department
of the Nasdaq Stock Market LLC (“ Nasdaq”) notifying the Company that it has regained compliance with the minimum bid price
requirement set forth in Nasdaq Listing Rule 5450(a)(2) (the “ Minimum Bid Price Requirement”) for continued listing on The
Nasdaq Capital Market.

As previously disclosed,
on October 16, 2025, the Company received a letter from Nasdaq, notifying the Company that it was not in compliance with the Minimum Bid
Price Requirement because the Company’s common stock, par value $0.001 (the “ Common Stock”), had closed below the $1.00
per share minimum for 30 consecutive business days. To regain compliance with the Minimum Bid Price Requirement, the Common Stock was
required to maintain a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days.

In its letter dated November
5, 2025, Nasdaq indicated the Company has regained compliance with the Minimum Bid Price Requirement, and the matter is now closed.

   2  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: November 6, 2025      Aethlon Medical, Inc.                                                           
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────
                              By:                        /s/ James B. Frakes                                  
                              Name:                      James B. Frakes                                      

   3